Ragweed Allergy Pipeline Review 2016: Therapeutics Report Covering 4 Companies & 5 Molecules - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Ragweed Allergy - Pipeline Review, H2 2016" report to their offering.

Ragweed Allergy pipeline therapeutics constitutes close to 5 molecules. which approximately 5 molecules are developed by Companies. Our latest report Ragweed Allergy - Pipeline Review, H2 2016, outlays comprehensive information on the therapeutics under development for Ragweed Allergy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

Ragweed Allergy Ragweed allergy occurs when ragweed pollen in the air enters the nose and throat of people who are allergic to that pollen, it can cause allergy and asthma symptoms. Symptoms include sneezing, runny or stuffy nose, itchy throat or inside of ears, hives, and swollen eyelids and itchy eyes. Treatment includes decongestant, antihistamine and nasal corticosteroid. The molecules developed by Companies in Phase II, Preclinical and Unknown stages are 1, 3 and 1 respectively.

Furthermore, this report also reviews of key players involved in therapeutic development for Ragweed Allergy and features dormant and discontinued projects.

Key Topics Covered:

  1. Introduction
  2. Ragweed Allergy Overview
  3. Therapeutics Development
  4. Pipeline Products for Ragweed Allergy - Overview
  5. Pipeline Products for Ragweed Allergy - Comparative Analysis
  6. Ragweed Allergy - Therapeutics under Development by Companies
  7. Ragweed Allergy - Therapeutics under Investigation by Universities/Institutes
  8. Ragweed Allergy Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Ragweed Allergy - Products under Development by Companies
  13. Ragweed Allergy - Products under Investigation by Universities/Institutes
  14. Ragweed Allergy - Companies Involved in Therapeutics Development
  • Anergis SA
  • Biomay AG
  • Circassia Pharmaceuticals Plc
  • Immunomic Therapeutics, Inc.

For more information about this report visit http://www.researchandmarkets.com/research/jvk8mn/ragweed_allergy

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Allergy Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Allergy Drugs